Demographic Drivers The GLP-1 analogues market, valued at USD 56.62 billion in 2025 and projected to grow at a CAGR of 21.39% from 2026 to 2034, is supported by expanded regulatory approvals for chronic weight management and cardiovascular risk reduction. Demographics add to this momentum. The geriatric population is at higher risk of diabetes and related conditions, and the report cites the UN...